Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Analyst picks & changes

Protein Design Labs Inc.

(PDLI)

Analysts maintained positive views of the company following the announcement that partner Corange was giving back

Read the full 216 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE